Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.

1000767276
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.

69.99 In Stock
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

by John Braithwaite
Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

Corporate Crime in the Pharmaceutical Industry (Routledge Revivals)

by John Braithwaite

Paperback(Reissue)

$69.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.


Product Details

ISBN-13: 9780415815642
Publisher: Taylor & Francis
Publication date: 05/14/2014
Series: Routledge Revivals
Edition description: Reissue
Pages: 450
Product dimensions: 5.44(w) x 8.50(h) x (d)

Table of Contents

Preface 1. Introduction: an industry case study of corporate crime 2. Bribery 3. Safety testing of drugs: from negligence to fraud 4. Unsafe manufacturing practices 5. Antitrust 6. The corporation as pusher 7. Drug companies and the Third World 8. Fiddling 9. Strategies for controlling corporate crime; Appendix: Getting interviews with corporate executives; Notes; Bibliography; Index

From the B&N Reads Blog

Customer Reviews